Steven Finkelstein, MD
Radiation Oncology · Syracuse, NYNPI 1700078409
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 60 manufacturers reported payments, led by Progenics Pharmaceuticals, Inc. at 25.2% of the total. Among radiation oncology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 962 payments — averaging $600.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Progenics Pharmaceuticals, Inc.$146K
- Bayer$139K
- Johnson & Johnson$72K
- Novartis$38K
- AstraZeneca$31K
- Astellas Pharma US Inc$28K
- plus $123K from 54 others
Across 12 payments — averaging $169,345 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$2M
- AstraZeneca$4K
What the payments were for
- Consulting fees$204,35035%
- Speaking & faculty fees$303,16352%
- Travel & lodging$49,1849%
- Food & beverage$21,2404%
- Education$940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PYLARIFY$145,132
- Xofigo$108,311
- Erleada$73,926
- XTANDI$35,737
- Nubeqa$31,965
- IMFINZI$28,655
- BIOPROTECT BALLOON IMPLANT SYSTEM$24,795
- PLUVICTO$17,366
- Axumin$15,631
- ELIGARD$13,440
- ORGOVYX$13,426
- POSLUMA$8,456
- SPACEOAR$5,000
- GENERAL BPH$4,400
- BAVENCIO$2,657
- Oncology$2,500
- ZYTIGA$1,755
- Lonsurf$1,713
- TAGRISSO$1,510
- Versa HD$361
How this compares
$578,032 in reported general payments places this provider in the 95th percentile of 397 radiation oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Syracuse
- Chung ChungSyracuse$3.1M
- Jeffrey BogartSyracuse$772K
- Michael ZelefskyNew York$946K
- Shawn ZimbergPlainview$411K
- Edward ObedianOyster Bay$391K
- Nancy LeeNew York$233K
- Dheerendra PrasadBuffalo$178K
- Robert SamsteinNew York$125K
- Jalal AhmedNew York$100K
- Chandan GuhaBronx$99K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.